Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of OTO-104 in unilateral Meniere's disease
2014-001337-86Phase 2Completed
- Sponsor
- Otonomy, Inc.
- Start
- May 2014
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Meniere Disease comparing OTO-104 with Placebo (2 arms). Primary endpoint: Adverse events. Started May 2014; status: completed.
02
Drugs
Otividex
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on 2014-001337-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001337-86.